23 lines
1.2 KiB
R
23 lines
1.2 KiB
R
|
#' Women's Interagency HIV Study
|
|||
|
|
#'
|
|||
|
|
#' A dataset containing competing risks information for women with HIV;
|
|||
|
|
#' recording the time to treatment, or the time to developing AIDS or death. The
|
|||
|
|
#' time may also be censored.
|
|||
|
|
#'
|
|||
|
|
#' @format A data frame with 1164 rows and 6 variables: \describe{
|
|||
|
|
#' \item{time}{time to the event} \item{status}{denotes which event occurred.
|
|||
|
|
#' 0 denotes censoring, 1 denotes HIV treatment began, and 2 denotes AIDS
|
|||
|
|
#' developed or the patient died} \item{ageatfda}{patient age at time first
|
|||
|
|
#' treatment approved} \item{idu}{binary specifying if the patient has a
|
|||
|
|
#' history of drug injections (1 if true)} \item{black}{binary specifying if
|
|||
|
|
#' the patient is black (1 if true)} \item{cd4nadir}{blood count of CD4 cells}
|
|||
|
|
#' }
|
|||
|
|
#' @source The data was obtained from the randomForestSRC R package.
|
|||
|
|
#'
|
|||
|
|
#' @references Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange
|
|||
|
|
#' S, Barranday Y, Holman S, Weber K, Young MA (2005). “The Women’s
|
|||
|
|
#' Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to
|
|||
|
|
#' the Bench.” Clinical and Vaccine Immunology, 12(9), 1013–1019.
|
|||
|
|
#' doi:10.1128/CDLI.12.9.1013-1019.2005.
|
|||
|
|
#'
|
|||
|
|
"wihs"
|